Extended knowledge of 115514-66-4

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Product Details of 115514-66-4, you can also check out more blogs about115514-66-4

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Product Details of 115514-66-4. Introducing a new discovery about 115514-66-4, Name is 4-Bromopyridazine

INHIBITORS OF CYCLIN DEPENDNT KINASE 7 (CDK7)

The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase 7 (CDK7), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Product Details of 115514-66-4, you can also check out more blogs about115514-66-4

Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N2108 – PubChem